IMU 0.00% 4.8¢ imugene limited

Media Thread, page-7314

  1. 237 Posts.
    lightbulb Created with Sketch. 1106
    Hi Zior,

    the best way to reference the abstracts is by their numbers

    Title: Combination immunotherapy using a novel chimeric oncolytic virus to redirect CD19 bispecific T cell engagers to target solid tumors Abstract #: 305

    Title: CF33-CD19t oncolytic virus (onCARlytics) targets hepatocellular carcinoma (HCC) and in combination with Artemis® CD19 T cells results in significant tumor killing Title: CF33-CD19t oncolytic virus (onCARlytics) targets hepatocellular carcinoma (HCC) and in combination with Artemis® CD19 T cells results in significant tumor killing Abstract #: 368

    Title: CF33-CD19t oncolytic virus (onCARlytics) in combination with off-the-shelf allogeneic CyCART-19 T cells targeting de novo CD19+ solid tumors Abstract #: 847 Title: CF33-CD19t oncolytic virus (onCARlytics) in combination with off-the-shelf allogeneic CyCART-19 T cells targeting de novo CD19+ solid tumors Abstract #: 847
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
0.000(0.00%)
Mkt cap ! $356.9M
Open High Low Value Volume
4.9¢ 4.9¢ 4.8¢ $328.5K 6.792M

Buyers (Bids)

No. Vol. Price($)
45 5443565 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 2171910 5
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.